http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1295951

Outgoing Links

Predicate Object
contentType Published Erratum
endingPage 1477
issn 1949-2553
issueIdentifier 16
pageRange 1474-1477
publicationName Oncotarget
startingPage 1474
bibliographicCitation Qu L, Lu Y, Ying M, Li B, Weng C, Xie Z, Liang L, Lin C, Yang X, Feng S, Wang Y, Shen X, Zhou Q, Chen Y, Chen Z, Wu J, Lin W, Shen Y, Qin J, Xu H, Xu F, Wang J, Chen J, Jiang H, Huang H. Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients. Oncotarget. 2020 Apr 21;11(16):1474–7. PMID: 32363004; PMCID: PMC7185064.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85504006461aa0eff5eca94aa4ea4757
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_617c07af39958cedf7dd21e05c9c4ed7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_128e342271c1a17c651b2d6037ffed57
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_002f563195731de0ead7fe37b72c8322
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab96e8d8c11d5a0859ea5abad5e9a6c3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63b34ba5bb8a9cfc8bd35b6e5a4a8d28
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95515e6bc111dbb87ede6a95820c40ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1d3e946c42697d09e5612aa530086d7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7da7745f6ffcb3399b13a1ee7a577844
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_554053cfcf288438a7babdb1970bca40
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c47da9f90a575a190acdac1404b8fdaf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0d15325478e14422b0af93f659a3031
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ac1af91320407b625f2084edbbab844
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a89e669bd1f5be8cc3ea7f7b34ca9fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_687d31c06b7b90d288048f87433dfc41
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7eb8d1b1c1d413e21fdc0a5f58693d72
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9793d1b1df5a365631890703760e385
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf7a61ffe10ad914e02bfc244879fc61
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46fdbc9119ec230387955b08bb1faf51
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2548d94014568815442987d36a70927
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef05b267e6ad150ed2ccae8fc029d93f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_013cd338a2aa3293290261e4f15c14a7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f61724e1e5fb78afe15f4b88ba227405
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49bc686228032cd2545e48c8f5096ea7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c78d681896ea3ad7cabd36f3c891879
date 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.18632/oncotarget.27561
https://pubmed.ncbi.nlm.nih.gov/32363004
https://pubmed.ncbi.nlm.nih.gov/PMC7185064
isPartOf https://portal.issn.org/resource/ISSN/1949-2553
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8535dce74a282d4ae5610eb102d132e9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445643

Total number of triples: 45.